Lv31
240 积分 2025-03-14 加入
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
2天前
已完结
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors
1个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
1个月前
已完结
Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy
1个月前
已完结
基于数据驱动和风险控制选择FIH起始剂量的策略和建议
1个月前
已完结
Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry
2个月前
已完结
DX-8951f: Summary of Phase I Clinical Trials
2个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
2个月前
已完结
Discovery of Potent and Brain-Penetrant Bicyclic NLRP3 Inhibitors with Peripheral and Central In Vivo Activity
2个月前
已完结
124 (PB112): Preclinical characterization of a Selective FGFR2/3 inhibitor, GSC000829
2个月前
已完结
皖公网安备34019202002308
